BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18485384)

  • 21. Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women.
    Stein JP; Esrig D; Freeman JA; Grossfeld GD; Ginsberg DA; Cote RJ; Groshen S; Boyd SD; Lieskovsky G; Skinner DG
    Urology; 1998 Jun; 51(6):951-5. PubMed ID: 9609632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benefits and risks of orthotopic neobladder reconstruction in female patients].
    Gakis G; Jentzmik F; Schrader M; Stenzl A; Sievert KD
    Aktuelle Urol; 2011 Mar; 42(2):109-14. PubMed ID: 21437834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ureteral and urethral recurrence after radical cystectomy: a systematic review.
    Carando R; Shariat SF; Moschini M; D'Andrea D
    Curr Opin Urol; 2020 May; 30(3):441-448. PubMed ID: 32235282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urethral recurrence in patients following orthotopic urinary diversion.
    Hassan JM; Cookson MS; Smith JA; Chang SS
    J Urol; 2004 Oct; 172(4 Pt 1):1338-41. PubMed ID: 15371836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.
    Nieder AM; Sved PD; Gomez P; Kim SS; Manoharan M; Soloway MS
    Urology; 2004 Nov; 64(5):950-4. PubMed ID: 15533484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic outcome and urinary function after radical cystectomy for rhabdomyosarcoma in children: role of the orthotopic ileal neobladder based on 15-year experience at a single center.
    Castagnetti M; Angelini L; Alaggio R; Scarzello G; Bisogno G; Rigamonti W
    J Urol; 2014 Jun; 191(6):1850-5. PubMed ID: 24384158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    Laukhtina E; Rajwa P; Mori K; Moschini M; D'Andrea D; Abufaraj M; Soria F; Mari A; Krajewski W; Albisinni S; Teoh JY; Quhal F; Sari Motlagh R; Mostafaei H; Katayama S; Grossmann NC; Enikeev D; Zimmermann K; Fajkovic H; Glybochko P; Shariat SF; Pradere B;
    Eur Urol Focus; 2022 May; 8(3):752-760. PubMed ID: 34127436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?
    Iselin CE; Robertson CN; Webster GD; Vieweg J; Paulson DF
    J Urol; 1997 Dec; 158(6):2123-6. PubMed ID: 9366327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; MÃ¥nsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Stein JP; Penson DF; Wu SD; Skinner DG
    J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary management of the urethra in patients after radical cystectomy for bladder cancer.
    Clark PE; Hall MC
    Urol Clin North Am; 2005 May; 32(2):199-206. PubMed ID: 15862617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of the urethra in men undergoing radical cystectomy for bladder cancer.
    Zabbo A; Montie JE
    J Urol; 1984 Feb; 131(2):267-8. PubMed ID: 6699956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.
    Abd El-Latif A; Watts KE; Elson P; Fergany A; Hansel DE
    J Urol; 2013 Apr; 189(4):1263-7. PubMed ID: 23085297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study.
    Su J; Zhu Q; Yuan L; Zhang Y; Zhang Q; Wei Y
    BJU Int; 2018 Jan; 121(1):111-118. PubMed ID: 28734080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma.
    Lerner SP; Colen J; Shen S
    Curr Opin Urol; 2008 Sep; 18(5):508-12. PubMed ID: 18670276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer.
    Brant A; Daniels M; Chappidi MR; Joice GA; Sopko NA; Matoso A; Bivalacqua TJ; Kates M
    World J Urol; 2019 Dec; 37(12):2683-2689. PubMed ID: 30850856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center.
    Chen ME; Pisters LL; Malpica A; Pettaway CA; Dinney CP
    J Urol; 1997 Jun; 157(6):2120-3. PubMed ID: 9146596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peroperative biopsy of the sub-apical urethra during prostatectomy for cancer].
    Ponthieu A; Delgrande J; Ivaldi A
    Prog Urol; 1996 Apr; 6(2):250-5; discussion 255-6. PubMed ID: 8777418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orthotopic bladder substitutes: histopathologic risk factors.
    Nabeeh A; Gomha M; Shaaban AA; el-Baz M; el-Dosoky I; Ashamallah A; Ghoneim MA
    Scand J Urol Nephrol; 1995 Dec; 29(4):463-7. PubMed ID: 8719364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.